October 10, 2023
Evonik introduces the world’s first carbon-fiber reinforced PEEK filament for long-term 3D printed medical implants
- VESTAKEEP® filament with 12% or 20% carbon-fiber content for adaptability to requirements of implants
- Alignment of carbon-fiber can be controlled during the 3D printing process
- Ideal balance of high strength, ductility and low weight makes PEEK an ideal metal-free alternative for implants
About Evonik
Evonik is one of the world leaders in specialty chemicals. The company is active in more than 100 countries around the world and generated sales of €15.3 billion and an operating profit (adjusted EBITDA) of €1.66 billion in 2023. Evonik goes far beyond chemistry to create innovative, profitable, and sustainable solutions for customers. About 32,000 employees work together for a common purpose: We want to improve life today and tomorrow.
Disclaimer
In so far as forecasts or expectations are expressed in this release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.
Online version press release